Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
November 14 2018 - 5:22PM
Edgar (US Regulatory)
|
UNITED STATES
|
|
|
SECURITIES AND EXCHANGE COMMISSION
|
SEC File No: 000-54563
|
|
Washington, D.C. 20549
|
CUSIP No: 74048 K 10 4
|
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [
X
] Form 10-Q [ ] Form
10-D [ ] Form N-SAR
[ ]
Form N-CSR
For Period
Ended:
September 30,
2018
☐
|
|
Transition
report on Form 10-K
|
☐
|
|
Transition
report on Form 20-F
|
☐
|
|
Transition
report on Form 11-K
|
☐
|
|
Transition
report on Form 10-Q
|
☐
|
|
Transition
report on Form N-SAR
|
For the Transition
Period Ended:
___________________________
Nothing in this form shall be construed to imply that the
Commission has verified any information contained
herein.
|
If the
notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification
relates:
__________________________________________________________________________
PART 1 -- REGISTRANT INFORMATION
|
|
Premier
Biomedical, Inc.
|
Full
Name of Registrant
|
|
Former
Name if Applicable
|
|
P.O.
Box 25
|
Address
of Principal Executive Office (
Street and Number)
|
|
Jackson
Center, PA 16133
|
City,
State and Zip Code
|
PART II -- RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if
appropriate)
☒
|
|
(a) The
reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
|
|
(b) The
subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or a
portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date;
and
|
|
(c) The
accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
|
PART III -- NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion
thereof, could not be filed within the prescribed time
period.
The
Form 10-Q could not be filed within the prescribed time period
because we need additional time to compile and review data and
other information regarding certain material operations of the
Company. This data and information are not currently available and
could not be made available without unreasonable effort and
expense. We are actively working to compile and review this
information.
PART IV-- OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this
notification
William
Hartman
|
814
|
786-8849
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
Have all other periodic reports required under
Section 13
or
15(d)
of the Securities Exchange Act of
1934 or Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the registrant
was required to file such report(s) been filed? If answer is no,
identify report(s).
[X ]Yes
[ ] No
(3) Is
it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
[ ]Yes
[ X ] No
If so,
attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Premier
Biomedical, Inc.
|
(Name
of Registrant as Specified in Charter)
|
has
caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date
|
November
14, 2018
|
By
|
/s/
William A. Hartman
|
|
|
|
William
A. Hartman
|
|
|
|
Chief
Executive Officer
|
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Apr 2023 to Apr 2024